Mitchell Sinkler & Starr Abb Vie Inc. Transaction History

Mitchell Sinkler & Starr

$422 Million
Q3 2024

A detailed history of Mitchell Sinkler & Starr transactions in Abb Vie Inc. stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 28,149 shares of ABBV stock, worth $4.94 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

28,149

Previous 22,337 26.02%

Holding current value

$4.94 Million

Previous $3.83 Million 45.08%

% of portfolio

1.32%

Previous 0.99%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $952,238 - $1.16 Million	5,812 Added 26.02%	28,149 $5.56 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $111,448 - $130,147	720 Added 3.33%	22,337 $3.83 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $6.43 Million - $7.32 Million	-40,205 Reduced 65.03%	21,617 $3.94 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $4.1 Million - $4.62 Million	29,822 Added 93.19%	61,822 $9.58 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $966,924 - $1.12 Million	7,238 Added 29.23%	32,000 $4.77 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $76,193 - $94,817	-575 Reduced 2.27%	24,762 $3.34 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $993,036 - $1.14 Million	6,867 Added 37.18%	25,337 $4.04 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $81,602 - $97,863	590 Added 3.3%	18,470 $2.99 Million
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $89,249 - $102,363	-665 Reduced 3.59%	17,880 $2.4 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $17,202 - $21,870	125 Added 0.68%	18,545 $2.84 Million
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $172,893 - $214,512	1,310 Added 7.66%	18,420 $2.99 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $31,691 - $40,099	295 Added 1.75%	17,110 $2.32 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $7,980 - $9,058	-75 Reduced 0.44%	16,815 $1.81 Million
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $18,414 - $20,271	-180 Reduced 1.05%	16,890 $1.83 Million
Q3 2020 Oct 07, 2020	BUY	$85.91 - $100.83 $31,357 - $36,802	365 Added 2.18%	17,070 $1.5 Million
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $154,077 - $206,178	-2,100 Reduced 11.17%	16,705 $1.64 Million
Q1 2020 Apr 07, 2020	SELL	$64.5 - $97.79 $33,862 - $51,339	-525 Reduced 2.72%	18,805 $1.43 Million
Q4 2019 Jan 09, 2020	SELL	$72.13 - $90.25 $43,638 - $54,601	-605 Reduced 3.03%	19,330 $1.71 Million
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $275,285 - $330,972	-4,371 Reduced 17.98%	19,935 $1.51 Million
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $6,570 - $8,398	-100 Reduced 0.41%	24,306 $1.77 Million
Q1 2019 Apr 08, 2019	SELL	$77.14 - $90.79 $86,782 - $102,138	-1,125 Reduced 4.41%	24,406 $1.97 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $141,687 - $174,738	-1,820 Reduced 6.65%	25,531 $2.35 Million
Q3 2018 Oct 04, 2018	SELL	$88.91 - $98.84 $92,021 - $102,299	-1,035 Reduced 3.65%	27,351 $2.59 Million
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $148,137 - $175,279	-1,650 Reduced 5.49%	28,386 $2.63 Million
Q1 2018 Apr 13, 2018	BUY	$92.01 - $123.21 $772,699 - $1.03 Million	8,398 Added 38.81%	30,036 $2.84 Million
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $59,646 - $65,407	-666 Reduced 2.99%	21,638 $2.09 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $1.56 Million - $1.99 Million	22,304	22,304 $1.98 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Abb Vie Inc. Transaction History